Articles From: Palatin Technologies, Inc. To Report First Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on November 14, 2013 to Sagent Pharmaceuticals Announces the Launch of Doxorubicin Hydrochloride Injection, USP


2013/11/11
Rare Element Resources Ltd.
Sign-up for Advantages of Proprietary Processing Technology Validated in Pilot Plant Tests investment picks
2013/11/11
WUXI, China , Nov.
Sign-up for Cleantech Solutions International Announces Conference Call to Discuss Third Quarter 2013 Financial Results investment picks
2013/11/11
Accenture (NYSE:ACN) has been named to G.I. Jobs’ 2014 Military Friendly Employers list.
Sign-up for Accenture Recognized on G.I. Jobs 2014 List of Military Friendly Employers investment picks
SHANGHAI, China, Nov.
Sign-up for JA Solar to Supply 70 MW of Modules to Shanghai CSET in China investment picks
2013/11/11
PROVO, Utah , Nov.
Sign-up for Nu Skin Receives Top Honors For Growth And Innovation investment picks
TARRYTOWN, N.Y., Nov.
Sign-up for Progenics Pharmaceuticals Announces Third Quarter Financial Results investment picks
TEL-AVIV, Israel, Nov.
Sign-up for Gazit-Globe to Report Third Quarter 2013 Financial Results on November 20, 2013 investment picks
FRANKFURT--The following is a summary of analysts' forecasts for European Aeronautic Defence and Space Co NV (EADSY) third-quarter results, based on a poll of 10 analysts conducted by Dow Jones Newswires (figures in million euros, EPS, dividend and target price in euro, according to IFRS). Earnings figures are scheduled to be released November 14.
Sign-up for EADS 3Q 2013 -- forecast investment picks
2013/11/11
Domino's offering two St.
Sign-up for Domino's Pizza® Kicks Off 2013 Thanks and Giving® Campaign for St. Jude Children's Research Hospital® investment picks
Folate Binding Protein (FBP) shown to be safe and immunogenic in its Phase 1 trial Phase 2a trial expected to initiate by year end PORTLAND, Ore., Nov.
Sign-up for Galena Biopharma Announces Initial Results From the Folate Binding Protein Vaccine Phase 1 Trial at the Society for Immunotherapy of Cancer Conference investment picks
2013/11/11
YOKNEAM, Israel , Nov.
Sign-up for Syneron Medical to Host Conference Call Today at 8:30 am ET to Discuss Global Joint Venture in Home Beauty Devices investment picks
2013/11/11
SAN FRANCISCO, Nov.
Sign-up for CollabRx Teams With Quest Diagnostics in Clinical Genetic Sequencing investment picks
Vista Gold Corp.
Sign-up for Vista Gold Corp. Announces Consolidation of Senior Corporate Responsibilities investment picks
2013/11/11
Ur-Energy to Present at Cowen and Company 4th Annual Global Metals, Mining & Materials Conference Canada NewsWire LITTLETON, Colo.
Sign-up for Ur-Energy to Present at Cowen and Company 4th Annual Global Metals, Mining & Materials Conference investment picks
2013/11/11
LITTLETON, Colo.
Sign-up for Ur-Energy to Present at Cowen and Company 4th Annual Global Metals, Mining & Materials Conference investment picks
2013/11/11
DENVER , Nov.
Sign-up for Vista Gold Corp. Announces Consolidation of Senior Corporate Responsibilities investment picks
2013/11/11
Ndablama and Weaju maiden resources exceed 600,000 oz gold Canada NewsWire TSX : AUE AIM : AUE TORONTO , Nov.
Sign-up for Ndablama and Weaju maiden resources exceed 600,000 oz gold investment picks
2013/11/11
WASHINGTON , Nov.
Sign-up for DuPont Fabros Technology, Inc. Names Jeffrey H. Foster As Chief Financial Officer investment picks
2013/11/11
LAS VEGAS , Nov.
Sign-up for Caesars Entertainment Announces Expiration and Results of Rights Offering investment picks
2013/11/11
HAYWARD, Calif.
Sign-up for Solta Medical to Present at CanaccordGenuity Medical Technology & Diagnostics Forum investment picks
2013/11/11
Spectrum Pharmaceuticals (Nasdaq: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the Company's business strategy and commercial and development-stage programs will be given at the Credit Suisse 2013 Healthcare Conference being held at the Phoenician in Scottsdale, Arizona.
Sign-up for Spectrum Pharmaceuticals to Present Corporate Update at the Credit Suisse 2013 Healthcare Conference in Arizona on November 13th investment picks
2013/11/11
EL PASO, Texas , Nov.
Sign-up for Foreclosed Homes in El Paso to be Restored with Help from Wells Fargo investment picks
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to patisiran (ALN-TTR02) for the treatment of transthyretin (TTR)-familial amyloid polyneuropathy (FAP). According to the FDA, Fast Track is a process designed to facilitate the development and expedite the review of drugs to treat serious conditions and fill an unmet medical need.
Sign-up for Alnylam Receives Fast Track Designation for Patisiran (ALN-TTR02), an RNAi Therapeutic Targeting Transthyretin (TTR) for the Treatment of TTR-Mediated Amyloidosis (ATTR) investment picks
2013/11/11
As Stewart continues to grow and offer targeted real estate services for our customer segments, we are proud to announce the creation of our National Homebuilder and Developer Sales team dedicated to the national and regional builder and developer community.
Sign-up for Stewart Title® Creates National Homebuilder and Developer Sales Team investment picks
SCHAUMBURG, Ill., Nov.
Sign-up for Sagent Pharmaceuticals Announces the Launch of Doxorubicin Hydrochloride Injection, USP investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Palatin Technologies, Inc. To Report First Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on November 14, 2013 to Sagent Pharmaceuticals Announces the Launch of Doxorubicin Hydrochloride Injection, USP
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity